Inventor · disambiguated record
Thomas Kuilman
Also filed as: KUILMAN THOMAS
2 granted patents·3 pending applications·0 citations·filing 2019–2022
23Inventor score
Files withNEOGENE THERAPEUTICS B V4STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS1
Top patents by PatentIndex Score
5 records- 0146US11629179B2TWEAK-receptor agonists for use in combination with immunotherapy of a cancerSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2019·Granted Apr 18, 2023·0 cites·20 claims
- 0236US12492386B2Methods to enrich genetically engineered T cellsNEOGENE THERAPEUTICS B V·Filed 2021·Granted Dec 9, 2025·0 cites·16 claims
- 0336US2022228164A1Engineered antigen presenting cellsNEOGENE THERAPEUTICS B V·Filed 2022·Application pending·0 cites
- 0436US2022195006A1Peptide markers to track genetically engineered cellsNEOGENE THERAPEUTICS B V·Filed 2021·Application pending·0 cites
- 0531US2021040558A1Method to isolate tcr genesNEOGENE THERAPEUTICS B V·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Kuilman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →